Cradle and UCB announced a strategic collaboration on November 4, 2026, to apply Cradle’s AI protein design and engineering platform within selected UCB antibody discovery projects, from hit generation through lead optimization and preclinical readiness. The collaboration adds Cradle’s end-to-end system to UCB’s expanding digital antibody discovery and engineering program. That program combines UCB’s existing antibody discovery platform with computational science, disease-biology expertise and…